CO4980896A1 - Nuevos derivados de piperidina un procedimiento para su preparacion y las composicones farmaceuticas que los contienen - Google Patents
Nuevos derivados de piperidina un procedimiento para su preparacion y las composicones farmaceuticas que los contienenInfo
- Publication number
- CO4980896A1 CO4980896A1 CO00008757A CO00008757A CO4980896A1 CO 4980896 A1 CO4980896 A1 CO 4980896A1 CO 00008757 A CO00008757 A CO 00008757A CO 00008757 A CO00008757 A CO 00008757A CO 4980896 A1 CO4980896 A1 CO 4980896A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- group
- atom
- piperidine
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuesto de Fórmula I: en la cual:- X representa un grupo R2 -N; un grupo R2 -CH:- Ar representa un fenilo monosustituido o disustituido por un átomo de halógeno; un(C1 -C3 )alquilo;- R1 representa un átomo de cloro, un átomo de bromo, un (C1 -C3 )alquilo o un trifluorometilo;- R2 representa un grupo -CR3 R4 CONR5 R6 ;- R3 y R4 representan el mismo radical elegido entre un metilo, un etilo, un n-propilo o unn-butilo;- o bien R3 y R4 junto con el átomo de carbono al cual están enlazados constituyen un (C3 -C6 )ciclo-alquilo;- R5 y R6 representan cada uno independientemente un hidrógeno; un (C1 -C3 )alquilo;- o bien R5 y R6 junto con el átomo de nitrógeno al cual estan enlazados constituyen un radical heterocíclico elegido entre el acetidin-1-ilo, el pirrolidin-1-ilo, el piperidin-1-ilo, elmorfolin-4-ilo, el tiomorfolin-4-ilo o el perhidroacepin-1-ilo;y sus sales con ácidos minerales u orgánicos, sus solvatos y/o sus hidratos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9901593A FR2789389B3 (fr) | 1999-02-10 | 1999-02-10 | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
FR9904429A FR2789390B3 (fr) | 1999-02-10 | 1999-04-07 | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4980896A1 true CO4980896A1 (es) | 2000-11-27 |
Family
ID=26234812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00008757A CO4980896A1 (es) | 1999-02-10 | 2000-02-10 | Nuevos derivados de piperidina un procedimiento para su preparacion y las composicones farmaceuticas que los contienen |
Country Status (37)
Country | Link |
---|---|
US (2) | US6642233B1 (es) |
EP (1) | EP1150970B1 (es) |
JP (1) | JP4648544B2 (es) |
KR (1) | KR100611261B1 (es) |
CN (1) | CN1273463C (es) |
AR (1) | AR028813A1 (es) |
AT (1) | ATE370942T1 (es) |
AU (1) | AU763716B2 (es) |
BG (1) | BG65031B1 (es) |
BR (1) | BR0008067A (es) |
CA (1) | CA2360894C (es) |
CO (1) | CO4980896A1 (es) |
CZ (1) | CZ300765B6 (es) |
DE (1) | DE60036081T2 (es) |
DK (1) | DK1150970T3 (es) |
EE (1) | EE04437B1 (es) |
ES (1) | ES2291187T3 (es) |
FR (1) | FR2789390B3 (es) |
HK (1) | HK1038927A1 (es) |
HR (1) | HRP20010566A2 (es) |
HU (1) | HUP0201281A3 (es) |
ID (1) | ID29219A (es) |
IL (2) | IL144363A0 (es) |
ME (1) | MEP11908A (es) |
NO (2) | NO321149B1 (es) |
NZ (1) | NZ513053A (es) |
PE (1) | PE20001463A1 (es) |
PL (1) | PL198561B1 (es) |
PT (1) | PT1150970E (es) |
RS (1) | RS50210B (es) |
RU (1) | RU2220956C2 (es) |
SI (1) | SI1150970T1 (es) |
SK (1) | SK286401B6 (es) |
TR (1) | TR200102331T2 (es) |
TW (1) | TWI254712B (es) |
UA (1) | UA70986C2 (es) |
WO (1) | WO2000047572A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009798A1 (en) | 2002-02-20 | 2005-01-13 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
AU2003217535A1 (en) * | 2002-02-20 | 2003-09-09 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids |
MXPA06008648A (es) * | 2004-01-30 | 2006-09-04 | Pfizer Prod Inc | Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion. |
FR2873373B1 (fr) * | 2004-07-23 | 2006-09-08 | Sanofi Synthelabo | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
GB2452696B (en) * | 2007-08-02 | 2009-09-23 | Cambridge Entpr Ltd | 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions |
DE102008015425A1 (de) * | 2008-03-20 | 2010-01-21 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid |
DE102008015426A1 (de) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen |
DE102008015428A1 (de) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US512901A (en) * | 1894-01-16 | Folding bed | ||
GB821012A (en) * | 1957-01-15 | 1959-09-30 | Rhone Poulenc Sa | New phenthiazine derivatives and processes for their preparation |
FR2676055B1 (fr) | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
ATE177095T1 (de) | 1994-08-25 | 1999-03-15 | Merrell Pharma Inc | Substituierte piperidine für die behandlung von allergischen krankheiten |
EP0714891A1 (en) | 1994-11-22 | 1996-06-05 | Eli Lilly And Company | Heterocyclic tachykinin receptor antagonists |
-
1999
- 1999-04-07 FR FR9904429A patent/FR2789390B3/fr not_active Expired - Lifetime
-
2000
- 2000-02-08 RS YUP-564/01A patent/RS50210B/sr unknown
- 2000-02-08 UA UA2001075184A patent/UA70986C2/uk unknown
- 2000-02-08 CZ CZ20012888A patent/CZ300765B6/cs not_active IP Right Cessation
- 2000-02-08 PT PT00903744T patent/PT1150970E/pt unknown
- 2000-02-08 US US09/913,106 patent/US6642233B1/en not_active Expired - Fee Related
- 2000-02-08 BR BR0008067-5A patent/BR0008067A/pt not_active Application Discontinuation
- 2000-02-08 TR TR2001/02331T patent/TR200102331T2/xx unknown
- 2000-02-08 HU HU0201281A patent/HUP0201281A3/hu unknown
- 2000-02-08 AU AU25531/00A patent/AU763716B2/en not_active Ceased
- 2000-02-08 DK DK00903744T patent/DK1150970T3/da active
- 2000-02-08 WO PCT/FR2000/000284 patent/WO2000047572A1/fr active IP Right Grant
- 2000-02-08 RU RU2001121989/04A patent/RU2220956C2/ru not_active IP Right Cessation
- 2000-02-08 EP EP00903744A patent/EP1150970B1/fr not_active Expired - Lifetime
- 2000-02-08 NZ NZ513053A patent/NZ513053A/xx not_active IP Right Cessation
- 2000-02-08 ES ES00903744T patent/ES2291187T3/es not_active Expired - Lifetime
- 2000-02-08 CN CNB008058261A patent/CN1273463C/zh not_active Expired - Fee Related
- 2000-02-08 PL PL350243A patent/PL198561B1/pl not_active IP Right Cessation
- 2000-02-08 JP JP2000598492A patent/JP4648544B2/ja not_active Expired - Fee Related
- 2000-02-08 SI SI200030968T patent/SI1150970T1/sl unknown
- 2000-02-08 AT AT00903744T patent/ATE370942T1/de not_active IP Right Cessation
- 2000-02-08 CA CA002360894A patent/CA2360894C/en not_active Expired - Fee Related
- 2000-02-08 KR KR1020017009983A patent/KR100611261B1/ko not_active IP Right Cessation
- 2000-02-08 IL IL14436300A patent/IL144363A0/xx not_active IP Right Cessation
- 2000-02-08 SK SK1139-2001A patent/SK286401B6/sk not_active IP Right Cessation
- 2000-02-08 DE DE60036081T patent/DE60036081T2/de not_active Expired - Lifetime
- 2000-02-08 ID IDW00200101651A patent/ID29219A/id unknown
- 2000-02-08 ME MEP-119/08A patent/MEP11908A/xx unknown
- 2000-02-08 EE EEP200100417A patent/EE04437B1/xx not_active IP Right Cessation
- 2000-02-09 AR ARP000100555A patent/AR028813A1/es active IP Right Grant
- 2000-02-09 TW TW089102106A patent/TWI254712B/zh active
- 2000-02-10 CO CO00008757A patent/CO4980896A1/es unknown
- 2000-02-10 PE PE2000000102A patent/PE20001463A1/es not_active Application Discontinuation
-
2001
- 2001-07-26 HR HR20010566A patent/HRP20010566A2/hr not_active Application Discontinuation
- 2001-08-08 NO NO20013878A patent/NO321149B1/no not_active IP Right Cessation
- 2001-08-08 BG BG105794A patent/BG65031B1/bg unknown
-
2002
- 2002-01-29 HK HK02100715A patent/HK1038927A1/xx not_active IP Right Cessation
-
2003
- 2003-09-16 US US10/663,124 patent/US6951940B2/en not_active Expired - Fee Related
-
2005
- 2005-04-21 NO NO20051958A patent/NO20051958L/no unknown
-
2007
- 2007-01-07 IL IL180579A patent/IL180579A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4970713A1 (es) | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen | |
CO5550440A2 (es) | Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona,su preparacion y su aplicacion en terapeutica | |
RS51007B (sr) | Supstituisani piridinil i pirimidinil derivati kao modulatori metabolizma i lečenje poremećaja proisteklih iz toga | |
ES2193990T3 (es) | Derivados de purina. | |
NO20050429L (no) | Substituert kinolin-CCR5-reseptorantagonister | |
AR039239A1 (es) | Compuestos que modulan la actividad ppar y procedimientos para su preparacion | |
ES2109987T3 (es) | Compuestos n-(aminoalquil)piperidina y sus enantiomeros como antagonistas de los receptores de las neuroquininas, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
CY1108313T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
CO6190523A2 (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
AR011623A1 (es) | Compuestos de sulfonamidas, procedimiento para prepararlos y composiciones farmaceuticas para potenciar las funciones de los glutamatoreceptores enmamiferos. | |
AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
CO5011090A1 (es) | Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos | |
ES2192520T3 (es) | Composicion farmaceutica. | |
ES2191484T3 (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa. | |
CO4980896A1 (es) | Nuevos derivados de piperidina un procedimiento para su preparacion y las composicones farmaceuticas que los contienen | |
AR062294A1 (es) | Derivados de 5,6 -bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii | |
DK190188D0 (da) | Aromatiske derivater og fremgangsmaade til fremstilling deraf samt deres anvendelse som antimikrobielle midler | |
CO5550439A2 (es) | Compuestos derivados de arilsulfonil-piperazina que tienen afinidad al receptor 5-ht6 y composiciones farmaceuticas que los contienen | |
CO5660263A2 (es) | Derivados de imidazol heteroaril sustituidos como antagonistas del receptor de glutamato | |
HUP0001165A2 (hu) | NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra | |
NI200900217A (es) | Derivados de sulfonil-quinolina | |
AR008168A1 (es) | Compuestos etilamino arilamida aril substituidos de pirrolidinilo y pirrolinilo, composicion farmaceutica que lo contiene, compuesto util para susintesis, procedimiento para su preparacion | |
AR069700A1 (es) | Derivados de azetidina,composiciones farmaceuticas que los comprenden, metodo de preparacion, intermediarios de sintesis,y usos de los mismos en el tratamiento o prevencion de trastornos psiquiatricos , del sistema inmune y gastrointestinales, entre otros. | |
CO5590914A2 (es) | Derivados de 5-(piridin-3-il)-1-azabiciclo [3.2.1] octano | |
RS50085B (sr) | Novi derivati morfolina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže |